TipHub

₹30.1

▼ -0.87 -2.81%

As of 29 Jul 2026 · delayed

BSE Listed

Shukra Pharmaceuticals Limited (524632)

Volume: 1,93,196Avg Vol 1W: 1,73,487Avg Vol 1M: 3,08,19752W Range:₹17.06₹65.26
BSE www.shukrapharmaceuticals.com AI Report
Key Ratios
Checked 7h ago
Market Cap₹1,318 Cr
Current Price₹30.1
Previous Close₹30.97
High / Low (52w)₹65.26 / ₹17.06
Volume1,93,196
Avg Vol (1W)1,73,487
Avg Vol (1M)3,08,197
Stock P/E60.2
Book Value₹2.05
Dividend Yield3%
ROE24.55%
ROA18.78%
Revenue (TTM)—
Revenue Growth—
Profit Margin38.88%
Total Debt—
Shares Outstanding44 Cr
Face Value—
EPS (TTM)₹0.5
P/B14.67
Debt / Equity0.06
50 DMA₹30.96
200 DMA₹38.44
Day change-2.81%
Price Chart
₹30.1▲ 45.41% · 1Y
₹87₹1615.7L
2025-07-30
2026-07-29

20-day avg volume: 3.3L shares

Pros
  • Healthy return on equity of 24.6%.
  • Pays a dividend yield of 3.0%.
  • Company is almost debt-free.
Cons
  • Revenue fell 84% YoY.
  • Company is loss-making at the latest annual result.
  • Stock trades at a high P/E of 60.
Quarterly Results
MetricDec 2024Mar 2025Sept 2025Dec 2025Mar 2026
Revenue₹11 Cr₹13 Cr₹6 Cr₹39 Cr₹6 Cr
EBITDA₹4 Cr₹8 Cr₹0 Cr₹27 Cr₹1 Cr
Net Profit₹3 Cr₹5 Cr₹2 Cr₹20 Cr₹-2 Cr
EPS—————
Profit & Loss (Annual)
MetricSept 2024Dec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹6 Cr₹11 Cr₹37 Cr₹13 Cr₹5 Cr₹6 Cr₹39 Cr₹6 Cr
EBITDA₹1 Cr₹4 Cr₹14 Cr₹8 Cr₹2 Cr₹0 Cr₹27 Cr₹1 Cr
Net Profit₹1 Cr₹3 Cr₹10 Cr₹5 Cr₹1 Cr₹2 Cr₹20 Cr₹-2 Cr
EPS——0.22—————
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹24 Cr₹28 Cr₹34 Cr₹36 Cr₹35 Cr₹75 Cr₹78 Cr₹87 Cr
Total Liabilities₹9 Cr₹13 Cr₹18 Cr₹20 Cr₹19 Cr₹50 Cr₹20 Cr₹24 Cr
Equity₹15 Cr₹15 Cr₹15 Cr₹16 Cr₹16 Cr₹25 Cr₹58 Cr₹63 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹1 Cr₹8 Cr₹3 Cr₹-5 Cr₹12 Cr
Investing₹-2 Cr₹-2 Cr₹-4 Cr₹-1 Cr₹-1 Cr
Financing₹2 Cr₹-7 Cr₹5 Cr₹12 Cr₹-5 Cr
Free Cash Flow₹1 Cr₹8 Cr₹3 Cr₹-5 Cr₹12 Cr
Shareholding
Promoter 50.96% Institutions 0.12% Public 48.92%
Efficiency & Working Capital
ROCE31.5%
Interest Coverage23.6
Dividend Payout—
Debtor Days98 d
Inventory Days111 d
Payable Days103 d
Cash Conversion Cycle106 d
Working Capital Days210 d
Shareholding Details

As of 2026-06-30

Promoter51%
FII0%
DII0.1%
Institutions0.1%
Public48.9%
Promoter Pledge0%
No. of Shareholders28,384
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters50.9%51%51%51%51%51%51%51%51%51%51%51%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%
Public49%48.9%48.9%48.9%48.9%48.9%48.9%48.9%48.9%48.9%48.9%48.9%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders9,74710,96312,97414,98916,32117,84418,23120,33721,44125,64927,17328,384
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Renuka Yogesh ParikhPublic Shareholding19.2%8.40 Cr
Yogesh Biharilal ParikhPublic Shareholding19.1%8.38 Cr
Anar Project Private LimitedShareholding of Promoter and Promoter Group18.8%8.22 Cr
Parshva Texchem India Private Ltd.Shareholding of Promoter and Promoter Group17.2%7.52 Cr
Navkar Surgical GujaratShareholding of Promoter and Promoter Group11.8%5.16 Cr
Anar Jayeshbhai PatelShareholding of Promoter and Promoter Group1%43,60,000
Dakshesh Rameshchandra ShahShareholding of Promoter and Promoter Group1%43,60,000
Sujay Jyotindra MehtaShareholding of Promoter and Promoter Group0.7%31,20,000
Payal Sujay MehtaShareholding of Promoter and Promoter Group0.5%22,80,000
Board of Directors
NameDesignationYear
Dakshesh ShahChairman / Executive Director / Managing Director2025
Payal MehtaExecutive Director2025
Dhruvin ShahE D & Wholetime Director2025
Sanskruti PatelE D & Wholetime Director2025
Pinki Nirmal SagarIndependent Non Exe. Director2025
Sonal Deepalbhai GandhiIndependent Non Exe. Director2025
Sarjeevan SinghIndependent Non Exe. Director2025
Jitendra shahIndependent Non Exe. Director2025
Anar Jayesh PatelExecutive Director / Whole Time Director / CFO2025
SHITAL DAKSHESH SHAHE D & Wholetime Director2025
Ritu KapoorIndependent Non Exe. Director2025
Shivkant DhakadCompany Secretary / Compliance Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹1494444
Corporate Actions
TypeDateValueRemark
dividend2025-09-18₹0.01 (1%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000404
2025000303
2025000101
Company Information
Incorporated1993
ChairmanDakshesh Shah
AuditorMAAK & Associates
Investor Email[email protected]
🌐 www.shukrapharmaceuticals.com ↗

📍 3 rd Floor Dev House, Opp WIAA Office Judges Bungalo, Ahmedabad, Gujarat, 380054

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Adline Chem Lab LimitedBeryl Drugs Ltd.IEL LimitediStreet Network LimitedGagan Gases Ltd.Parker Agrochem Exports LimitedAlufluoride Ltd.Oxygenta Pharmaceutical LimitedArchit Organosys Ltd.Sikozy Realtors LimitedIndo AminesNatural CapsulesAll “52” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search